Recent advances in the systemic treatment of metastatic non-clear cell renal cell carcinomas.

Ito, Keiichi

Ito, Keiichi.

Affiliation

Ito K; Department of Urology, National Defense Medical College, Tokorozawa, Saitama, Japan.

Int J Urol ; 26(9): 868-877, 2019 09.

Article in En | MEDLINE | ID: mdl-31183903

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carcinoma, Renal Cell/drug therapy; Kidney Neoplasms/drug therapy; Protein Kinase Inhibitors/therapeutic use; Biomarkers, Tumor/genetics; Carcinoma, Renal Cell/genetics; Carcinoma, Renal Cell/mortality; Carcinoma, Renal Cell/secondary; Clinical Trials as Topic; Humans; Kidney Neoplasms/genetics; Kidney Neoplasms/mortality; Kidney Neoplasms/pathology; Mutation; Progression-Free Survival

Key words

immuno-oncology drug; mammalian target of rapamicin inihibitor; non-clear cell renal cell carcinoma; targeted therapy; tyrosine kinase inhibitor

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Renal Cell / Antineoplastic Combined Chemotherapy Protocols / Protein Kinase Inhibitors / Kidney Neoplasms Type of study: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Language: En Journal: Int J Urol Year: 2019 Type: Article Affiliation country: Japan

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google